effect of continued weekly subcutaneous semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial STEP 4: Effect of Weekly

10.1172/JCI129710 165 MilatovicD.YinZ.GuptaR

Dovizio M, Leogrande M, Esposti LD Global & regional health technology assessment

The GLP-1 Big Pharma Journey The story of GLP-1 drugs spans decades and multiple pharmaceutical giants, including Eli Lilly and Novo Nordisk, which were involved from the early years

Redness, swelling, mild induration

March 2, 2026 NAION Warning In the U.K., the Medicines and Healthcare products Regulatory Agency has issued a safety update warning that semaglutide, the widely used diabetes and weight loss drug sold as Wegovy, Ozempic and Rybelsus, may be linked in rare cases to a serious eye condition that can cause sudden vision loss

Researchers have observed that administering Actiwave to strawberry plants via soil drenching leads to a notable increase in the weight of their roots (Shukla et al., 2019